Kanazawa University research: Promising anticancer molecule identified
KANAZAWA, Japan, April 29, 2022 /PRNewswire/ -- Researchers at Kanazawa University in collaboration with teams from Toyama Prefectural University and BioSeeds Corporation report in ACS Applied Materials & Interfaces the identification of a molecule with enhanced antiproliferative activity in cancer cells.
- KANAZAWA, Japan, April 29, 2022 /PRNewswire/ -- Researchers at Kanazawa University in collaboration with teams from Toyama Prefectural University and BioSeeds Corporation report in ACS Applied Materials & Interfaces the identification of a molecule with enhanced antiproliferative activity in cancer cells.
- Now, Madhu Biyani from Kanazawa University and colleagues have identified a DNA-derived molecule that binds to and inhibits the function of CYP24 and shows promising antiproliferative activity.
- Quoting Biyani and colleagues, these findings "clearly characterized and proposed that a DNA aptamer-based molecule could be a promising lead candidate for anticancer therapy.
- Madhu Biyani from Kanazawa University and colleagues have now identified a molecule (Apt-7) that inhibits CYP24, and as such displays antiproliferative activity in cancer cells.